catalyst · primary record
Lasofoxifene in combination with abemaciclib + Fulvestrant in combination with abemaciclib
Phase readout · 2027-04-01 · Metastatic Breast Cancer
| Company | LeonaBio |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | P3 primary completion · NCT05696626 |
| Source | ClinicalTrials.gov |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:51.132Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: LeonaBio:Lasofoxifene in combination with abemaciclib + Fulvestrant in combination with abemaciclib:2027-04-01:P3 primary completion · NCT05696626
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.